Education
About Us
Working with TipRanks
Follow Us
Athira Pharma (ATHA)
NASDAQ:ATHA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -969.00K | $ -1.05M | $ -479.00K | $ -2.00M |
| Operating Income | $ -100.90M | $ -125.47M | $ -104.02M | $ -64.02M | $ -20.00M |
| EBITDA | $ -100.90M | $ -116.70M | $ -94.59M | $ -54.37M | $ -19.01M |
| Net Income | $ -96.94M | $ -117.67M | $ -87.26M | $ -54.37M | $ -18.63M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 51.27M | $ 147.42M | $ 200.34M | $ 253.76M | $ 184.68M |
| Total Assets | $ 58.78M | $ 160.25M | $ 258.15M | $ 332.01M | $ 279.56M |
| Total Debt | $ 1.22M | $ 1.58M | $ 1.91M | $ 1.92M | $ 1.00M |
| Net Debt | $ -47.22M | $ -89.00M | $ -94.06M | $ -108.62M | $ -59.63M |
| Total Liabilities | $ 13.94M | $ 30.06M | $ 23.02M | $ 10.92M | $ 5.28M |
| Stockholders' Equity | $ 44.84M | $ 130.19M | $ 235.14M | $ 321.08M | $ 274.28M |
| Cash Flow | |||||
| Free Cash Flow | $ -97.20M | $ -101.06M | $ -73.61M | $ -44.67M | $ -26.43M |
| Operating Cash Flow | $ -97.17M | $ -100.75M | $ -72.47M | $ -43.10M | $ -24.11M |
| Investing Cash Flow | $ 54.83M | $ 95.09M | $ 57.66M | $ -4.08M | $ -210.07M |
| Financing Cash Flow | $ 194.00K | $ 493.00K | $ 654.00K | $ 97.09M | $ 292.75M |